BioRestorative Therapies ...

NASDAQ: BRTX · Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT

BioRestorative Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.66M -5.34M -1.64M -1.09M -4.03M -2.22M 1.17M -2.93M -2.98M -5.68M -4.35M -4.66M -4.68M -4.82M -20.4M -4.18M -4.06M -15.65M
Depreciation & Amortization
52.75K 51.78K 50.37K 48.27K 47.7K 42.71K 42.71K 42.15K 41.53K 39.35K 31.79K 31.23K 31.52K 26.01K 21.5K 21.58K 21.83K 24.2K
Stock-Based Compensation
468.71K 2.01M 175.63K 284.25K 324.32K 2.03M 1.46M 1.49M 1.45M 3.38M 3.06M 3.07M 3.1M 3.38M 3.18M 2.93M 2.93M 14.08M
Other Working Capital
68.84K -311.05K 30.3K 174.91K 200.37K -501.51K 147.03K 244.22K 108.54K 39.65K -66.8K -11.76K 95.1K -111.48K -143.01K 296.2K 502.46K 1.3M
Other Non-Cash Items
-648.33K 531.32K -1.03M -1.16M 1.6M -1.69M -3.01M 29.01K 29.01K -4.39K 19.53K 48.91K 29.01K -220.99K 94.05K 375.98K 378.56K 422K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.57M 40.99K 11.01K n/a n/a n/a n/a n/a 16.18M n/a n/a n/a
Change in Working Capital
89.27K -31.21K 88.59K 222.77K 192.99K -475.7K 129.06K 141.93K 283K -38.66K -335.4K 49.51K 259.44K 40.59K -216.74K 230.85K -6.09K 316.67K
Operating Cash Flow
-2.69M -2.78M -2.35M -1.7M -1.87M -2.32M -1.77M -1.18M -1.13M -2.35M -1.57M -1.45M -1.25M -1.59M -1.15M -629.36K -741.83K -813.7K
Capital Expenditures
n/a n/a -12.43K -58.46K -35.3K n/a -70.02K -11.95K -29.05K -60.02K -217.58K 24.61K -137.67K -109.57K -30.66K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -170.69K 437.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-1.08M -1.05M -2.59M -5.51M -2.06M -10.73M -17.1M -437.84K -6.07M -1.47M -3.11M -9.93M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
3.21M 3.46M 4.14M 6.51M 5.07M 5.8M 17.27M 426.73K 694.85K 2.57M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 170.69K -437.84K 694.85K 2.57M -3.2M -9.93M n/a -109.57K -30.66K n/a n/a n/a
Investing Cash Flow
2.13M 2.37M 1.53M 936.75K 2.97M -4.93M 100.67K -23.06K 665.8K 2.51M -3.32M -9.91M -137.67K -109.57K -30.66K n/a n/a n/a
Debt Repayment
n/a -33.61K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 250K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-73.74K n/a -131.32K -340.88K n/a -151.6K -569.07K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
73.74K 33.61K 5.01K 340.88K -12.84K 142.06K 569.07K n/a 411.7K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
888.14K 1.09M -126.32K n/a -12.84K 7.52M 83.07K 1.85M 411.7K n/a n/a n/a n/a n/a 21.07M n/a n/a 250K
Net Cash Flow
326.46K 680.9K -941.55K -762.8K 1.1M 272.7K -1.55M 653.22K -52.82K 159.89K -4.9M -11.36M -1.39M -1.7M 19.9M -629.36K -741.83K -563.7K
Free Cash Flow
-2.69M -2.78M -2.36M -1.76M -1.9M -2.32M -1.84M -1.19M -1.16M -2.41M -1.79M -1.43M -1.39M -1.7M -1.18M -629.36K -741.83K -813.7K